| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/19/2003 | WO2002077237A3 Transporters and ion channels |
| 06/19/2003 | WO2002077020A3 Virulence genes in h. influenzae |
| 06/19/2003 | WO2002062847A3 Superficial zone protein and methods of making and using same |
| 06/19/2003 | WO2002061131A3 Human single nucleotide polymorphisms |
| 06/19/2003 | WO2002061087A3 Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides |
| 06/19/2003 | WO2002057439A3 Plant transcription factors |
| 06/19/2003 | WO2002048376A3 Bacterial host strains |
| 06/19/2003 | WO2002048172A3 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 06/19/2003 | WO2002044375A3 Compositions and methods for diagnosing or treating psoriasis |
| 06/19/2003 | WO2002044342A9 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 06/19/2003 | WO2002042499A3 Compositions and methods relating to prostate specific genes and proteins |
| 06/19/2003 | WO2002042462A3 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 06/19/2003 | WO2002030979A3 Polypeptides homologous to thymosin, ephrin a receptors, and fibromodulin, and polynucleotides encoding same |
| 06/19/2003 | WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same |
| 06/19/2003 | WO2002026815A3 Identification of neuroblastoma tumor suppressor genes |
| 06/19/2003 | WO2002022153A3 Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation |
| 06/19/2003 | WO2002020734A3 Crystallized cytoplasmic tie2 receptor tyrosine kinase domain and method of determining and designing modulators of the same |
| 06/19/2003 | WO2002012343A3 Proteins and nucleic acids encoding g-protein coupled receptors |
| 06/19/2003 | WO2002010205A3 Mutations of the mdr1 p-glycoprotein that improve its ability to confer resistance to chemotherapeutic drugs |
| 06/19/2003 | WO2002004514A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/19/2003 | WO2001096389A3 Compositions and methods for the therapy and diagnosis of colon cancer |
| 06/19/2003 | WO2001015676A9 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 06/19/2003 | WO2001008635A3 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 06/19/2003 | US20030115639 Expressed sequences of arabidopsis thaliana |
| 06/19/2003 | US20030115637 Embryo sac-specific genes |
| 06/19/2003 | US20030115636 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 06/19/2003 | US20030115635 Controlling gene expression, apoptosis in plants |
| 06/19/2003 | US20030115634 Dna sequence from Plasmodium; detection of herbicides, viricides, bactericides, fungicides |
| 06/19/2003 | US20030115631 Transgenic plants; prevent diseases |
| 06/19/2003 | US20030115630 Insecticide for transgenic corn; genetic engineering |
| 06/19/2003 | US20030115629 Novel OrfF and OrfF' polypeptides, nucleic acid molecules encoding the polypeptides and applications thereof |
| 06/19/2003 | US20030115628 Nucleotide sequences coding for polypeptides endowed with a larvicidal activity towards lepidoptera |
| 06/19/2003 | US20030115627 Genetic engineering; isolated nucleic acid |
| 06/19/2003 | US20030115626 Genetic engineereed herbicide; controlling weeds |
| 06/19/2003 | US20030115621 Detection of central nervous system disorders using tau protein |
| 06/19/2003 | US20030115620 Major histocompatibility complex; transgenic swine |
| 06/19/2003 | US20030115619 Animal with reduced sensitivity to disease |
| 06/19/2003 | US20030115617 Transgenic animal; antidiabetic agents, anxiolytic agents, analgesics, antiepileptic agents |
| 06/19/2003 | US20030115616 Transgenic animal; urokinase plasminogen activator; viricides; detecting liver toxicity |
| 06/19/2003 | US20030114724 Polyubiquitin based hydrogel and uses thereof |
| 06/19/2003 | US20030114659 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| 06/19/2003 | US20030114658 Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use |
| 06/19/2003 | US20030114657 Central nervous system disorders; brain disorders |
| 06/19/2003 | US20030114654 Antithrombin nucleotides and proteins from horn fly |
| 06/19/2003 | US20030114652 Hybrid polypeptide; genetic engineering |
| 06/19/2003 | US20030114650 Modulation gene expression |
| 06/19/2003 | US20030114646 Human cystatin F |
| 06/19/2003 | US20030114645 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 06/19/2003 | US20030114644 Melanin concentrating hormone receptors |
| 06/19/2003 | US20030114643 Regulation of human serotonin-like g protein-coupled receptor |
| 06/19/2003 | US20030114529 HO-NH-(C=O)-CH2-CH(-CH2-CH(CH3)2)-(C=O)-V-,V=valine or another amino acid connected with an amino acid sequence of 10 or more amino acids; useful for treating diseases caused by cartilage degradation |
| 06/19/2003 | US20030114413 A nucleotide sequence coding for a protein comprising a positive function in a regulatory pathway, e.g Drosophila Legless (Lgs) protein; component of the Wnt/Wingless (Wnt/Wg) signal transduction; anticarcinogenic and -tumor agents |
| 06/19/2003 | US20030114404 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 06/19/2003 | US20030114399 Human and mouse choline transporter cDNA |
| 06/19/2003 | US20030114398 Monoclonal antiidiotype antibody 1A7 eliciting an anti-ganglioside GD2 response and overcomes immune tolerance; detecting an anti-GD2 antibody bound to a tumor cell; kits; melanoma, neuroblastoma, glioma, soft tissue sarcoma |
| 06/19/2003 | US20030114383 Calcitonin-like sequence expressed by gonadotropes of the anterior pituitary |
| 06/19/2003 | US20030114380 Amino acid sequence has 87-99 peptide residues |
| 06/19/2003 | US20030114379 Encoded protein for treating leukemia, leukocytes, and bone marrow stem cell colony formation |
| 06/19/2003 | US20030114378 Mouse pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation |
| 06/19/2003 | US20030114377 Domain binds component from a foreign body selected from gramnegative bacteria and grampositive bacteria, lipopolysaccharide transmitting cellular signals |
| 06/19/2003 | US20030114375 Method for treating cystic fibrosis |
| 06/19/2003 | US20030114374 Production of vascular endothelial cell growth factor and DNA encoding same |
| 06/19/2003 | US20030114372 Isolated DNA encoding amino acid sequences, serine protease inhibitor, host cell transformed with a DNA molecule, Kunitz type Inhibitor, blood coagulation factors |
| 06/19/2003 | US20030114371 Hybridizable nucleic acid, cDNA sequence, recombinant vector and host cells, isolated antibody; a neural disorder related to drug addiction, immune disorder, transplant rejection, cell proliferative disorder, cancer treatment; drug screening |
| 06/19/2003 | US20030114370 Nucleic acid molecules encoding endostatin protein and peptide fragments thereof |
| 06/19/2003 | US20030114369 HIV-specific CTL inducing peptides and medicaments for preventing or treating AIDS comprising the peptides |
| 06/19/2003 | US20030114368 Immunotoxins directed against malignant cells |
| 06/19/2003 | US20030114362 Radical of an amino carboxylic acid bearing a five- membered ring in the peptide backbone; antitumour agents |
| 06/19/2003 | US20030114360 Peptide of lysine and tyrosine; viricides; treating neurodegenerative disorders |
| 06/19/2003 | US20030114354 Computer for producing a three-dimensional representation of a molecule or molecular complex |
| 06/19/2003 | US20030113919 Anticancer agents |
| 06/19/2003 | US20030113918 Gene therapy; expression of polynucleotide in nucleic acids in dopaminergic cell; Parkinson's disease |
| 06/19/2003 | US20030113909 G protein coupled receptor protein, production and use thereof |
| 06/19/2003 | US20030113899 Method for producing L-arginine |
| 06/19/2003 | US20030113898 Methods for producing high titre vectors and compositions used in such methods |
| 06/19/2003 | US20030113897 Genetic engineering; anticancer agents |
| 06/19/2003 | US20030113896 Medical diagnosis; detection of antibodies |
| 06/19/2003 | US20030113895 Proteases from gram-positive organisms |
| 06/19/2003 | US20030113894 Therapy for kidney diseases; cardiovascular disorders |
| 06/19/2003 | US20030113892 Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use |
| 06/19/2003 | US20030113890 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 06/19/2003 | US20030113889 FARS1, a human secreted protein and uses thereof |
| 06/19/2003 | US20030113888 Human ion channels |
| 06/19/2003 | US20030113881 D-enzyme compositions and methods of their use |
| 06/19/2003 | US20030113873 Screening modulators of G-protein coupled binding proteins; analgesics; muscle-relaxants; cognition activators; learning enhancement |
| 06/19/2003 | US20030113871 Glycoprotein hormones; human chorionic gonadotropin; carboxy terminal peptides (ctp); increaseing half life of polypeptides; antipernicious anemia drugs |
| 06/19/2003 | US20030113870 Polypeptides homologous to VEGF and BMP1 |
| 06/19/2003 | US20030113869 Human FGF gene and gene expression products |
| 06/19/2003 | US20030113868 Human metabotropic glutamate receptor subtype mGluR7b |
| 06/19/2003 | US20030113867 Muscle receptor proteins; transport proteins; antitumor agents; antiinflammatory agents; antidiabetic agents; modulation of muscle contraction |
| 06/19/2003 | US20030113865 Transmembrane polypeptides; erythropoietins; colony stimulating factors; interleukin receptors; somatotropins; antiproliferative agents; kinases; antiarthritic agents; antiniflammatory agents |
| 06/19/2003 | US20030113864 Induction of chondrocyte proliferation/differentiation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis |
| 06/19/2003 | US20030113863 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/19/2003 | US20030113862 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/19/2003 | US20030113861 Induction of chondrocyte differentiation/proliferation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis |
| 06/19/2003 | US20030113860 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/19/2003 | US20030113859 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/19/2003 | US20030113858 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/19/2003 | US20030113857 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/19/2003 | US20030113856 Secreted and transmembrane polypeptides and nucleic acids encoding the same |